Conference abstract
Pharmacometabolomics-guided pharmacogenomics in precision medicine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Inter-individual variability has been a major hurdle to optimize disease management. Precision medicine holds promise for improving health and healthcare via tailor-made therapeutic strategies. Herein, we outline the paradigm of pharmacometabolomics-guided pharmacogenomics. We envisage merging pharmacometabolomic and pharmacogenomic data (to address the interplay of genomic and environmental influences) with information technologies to facilitate data analysis as well as sense and decision-making on the basis of synergy between artificial and human intelligence. Humans can detect patterns, which computer algorithms may fail to do so, whereas data-intensive and cognitively complex settings and processes limit human ability. We propose that better-informed, rapid and cost-effective multi-omics studies coupled to information technologies allow for data reproducibility and robustness in genotype-to-phenotype correlations.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiochemistry & Molecular Biology Journal
- SubjectBiochemistry & Biotechnology
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Theodora Katsila”
- BylineArticles whose byline prints “George P Patrinos”